Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction: Results of the thrombolysis in myocardial infarction (TIMI), phase II trial

Edwin G. Bovill, Michael L. Terrin, David C. Stump, Andrew D. Berke, Margaret Frederick, Désiré Collen, Frederick Feit, Joel M. Gore, L. David Hillis, Costas T. Lambrew, Roy Leiboff, Kenneth G. Mann, John E. Markis, Craig M. Pratt, Scott W. Sharkey, George Sopko, Russell P. Tracy, James H. Chesebro

Research output: Contribution to journalArticlepeer-review

403 Scopus citations

Fingerprint

Dive into the research topics of 'Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction: Results of the thrombolysis in myocardial infarction (TIMI), phase II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences